NVE Corp
NVEC
113.82
+2.37
+2.13%
NVE Corp
US · NVEC
#3698 by market cap
113.82
+2.37
+2.13%
Live - 5344 symbols - heartbeat 81s ago
· 2026-10-09 19:30
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 157.90, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.76% YoY
Margins
- Gross margin
- 78.73%
- Operating margin
- 60.46%
- Net margin
- 57.72%
Key ratios & quality
- Altman Z-Scorei
- 157.90
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 26.47M | 25.41M | 21.37M | 26.99M | 38.25M | 29.80M | 25.87M | 26.33M |
| Gross profit | 21.26M | 20.52M | 17.24M | 20.72M | 30.19M | 23.03M | 21.64M | 20.73M |
| Selling & admin expenses | 1.22M | 1.32M | 1.32M | 1.47M | 1.96M | 1.77M | 2.01M | 1.65M |
| Research & development | 4.11M | 3.69M | 3.18M | 2.93M | 2.58M | 2.73M | 3.64M | 3.16M |
| Operating profit | 15.92M | 15.51M | 12.74M | 16.33M | 25.64M | 18.52M | 15.99M | 15.92M |
| Pretax profit | 17.71M | 17.30M | 14.24M | 17.50M | 27.09M | 20.47M | 18.04M | 17.82M |
| Tax | 3.20M | 2.78M | 2.55M | 2.99M | 4.40M | 3.34M | 2.97M | 2.62M |
| Net profit | 14.51M | 14.53M | 11.69M | 14.51M | 22.69M | 17.12M | 15.06M | 15.20M |
| Basic EPS | 3 | 3 | 2 | 3 | 5 | 4 | 3 | 3 |
| Diluted EPS | 2.99 | 3.00 | 2.42 | 3.00 | 4.70 | 3.54 | 3.11 | 3.14 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 7.27M | 6.10M | 6.35M | 6.22M | 7.65M | 11.03M |
| Gross profit | 5.75M | 4.92M | 4.97M | 4.89M | 5.95M | 8.97M |
| Selling & admin expenses | 465.82K | 418.64K | 436.92K | 352.14K | 443.10K | 755.59K |
| Research & development | 1.04M | 720.23K | 873.47K | 795.59K | 771.20K | 946.58K |
| Operating profit | 4.25M | 3.78M | 3.66M | 3.74M | 4.73M | 7.27M |
| Pretax profit | 4.73M | 4.28M | 4.15M | 4.21M | 5.18M | 7.72M |
| Tax | 833.37K | 706.45K | 834.70K | 821.69K | 254.29K | 1.32M |
| Net profit | 3.89M | 3.58M | 3.31M | 3.38M | 4.93M | 6.39M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.80 | 0.74 | 0.68 | 0.70 | 1.02 | 1.32 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 27.44M | 34.38M | 24.36M | 41.50M | 30.79M | 33.19M | 33.20M | 32.19M |
| Cash & ST investments | 19.37M | 27.15M | 18.11M | 31.29M | 17.18M | 22.20M | 21.73M | 19.84M |
| Inventory | 4.26M | 3.88M | 3.90M | 5.09M | 6.42M | 7.16M | 7.45M | 7.08M |
| Total assets | 83.62M | 79.50M | 72.50M | 67.47M | 69.26M | 66.78M | 64.28M | 60.38M |
| Total current liabilities | 835.68K | 796.20K | 1.03M | 2.46M | 1.83M | 1.04M | 1.17M | 1.14M |
| Short-term debt | -- | 127.13K | 150.27K | 156.12K | 175.80K | 179.37K | 83.01K | 165.12K |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 835,676.00 | 1,502,801.00 | 1,608,797.00 | 2,902,363.00 | 2,175,668.00 | 1,211,516.00 | 2,007,091.00 | 2,130,033.00 |
| Total equity | 82.78M | 78.00M | 70.89M | 64.57M | 67.08M | 65.57M | 62.27M | 58.25M |
| Retained earnings | 62.90M | 58.05M | 50.40M | 45.58M | 48.95M | 46.74M | 42.47M | 38.32M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 33.20M | 26.17M | 28.77M | 31.08M | 32.19M | 35.68M |
| Cash & ST investments | 21.73M | 15.83M | 17.75M | 20.57M | 19.84M | 21.77M |
| Inventory | 7.45M | 7.45M | 7.42M | 7.27M | 7.08M | 6.67M |
| Total assets | 64.28M | 63.55M | 61.49M | 59.96M | 60.38M | 62.12M |
| Total current liabilities | 1.17M | 1.63M | 970.72K | 891.98K | 1.14M | 1.50M |
| Short-term debt | 83.01K | 53.82K | 155.80K | 160.41K | 165.12K | 201.01K |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 2,007,091.00 | 2,463,940.00 | 1,777,263.00 | 1,665,975.00 | 2,130,033.00 | 2,337,150.00 |
| Total equity | 62.27M | 61.09M | 59.71M | 58.30M | 58.25M | 59.78M |
| Retained earnings | 42.47M | 41.21M | 39.68M | 38.23M | 38.32M | 39.88M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 14.22M | 15.90M | 13.36M | 12.50M | 19.09M | 18.25M | 14.31M | 16.66M |
| Depreciation & amortization | 705.20K | 549.97K | 542.93K | 424.98K | 196.74K | 308.15K | 324.23K | 460.03K |
| Free cash flow | 14.15M | 15.84M | 13.30M | 12.02M | 18.16M | 18.23M | 13.05M | 14.47M |
| Dividends paid | -19.37M | -19.38M | -19.34M | -19.33M | -19.32M | -19.33M | -19.34M | -19.35M |
| Stock buybacks / issuance | 0 | -687.43K | -91.42K | -163.52K | -20.70K | -- | -- | -- |
| Ending cash balance | 6.88M | 8.07M | 10.43M | 10.45M | 1.67M | 10.28M | 8.04M | 1.71M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 2.48M | 5.19M | 2.79M | 4.19M | 4.49M | 5.31M |
| Depreciation & amortization | 82.42K | 85.40K | 89.05K | 94.36K | 191.22K | 232.35K |
| Free cash flow | 2.39M | 4.13M | 2.72M | 3.14M | 4.48M | 5.25M |
| Dividends paid | -4.84M | -4.84M | -4.84M | -4.84M | -4.84M | -4.84M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 8.04M | 3.22M | 5.11M | 3.41M | 1.71M | 2.90M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 17.15 | 18.07 | 15.71 | 21.42 | 34.48 | 25.82 | 23.57 | 25.22 |
| ROA %i | 16.96 | 17.81 | 15.39 | 20.73 | 33.20 | 25.18 | 22.99 | 24.39 |
| ROIC %i | 15.42 | 16.04 | 13.91 | 19.79 | 32.35 | 23.20 | 20.87 | 22.21 |
| 5-year avg ROE %i | 14.31 | 15.22 | 15.99 | 17.58 | 21.37 | 23.10 | 24.20 | 26.10 |
| EBIT margin %i | 60.16 | 61.05 | 59.64 | 60.51 | 67.04 | 62.14 | 61.81 | 60.46 |
| FCF / sales %i | 53.45 | 62.35 | 62.26 | 44.54 | 47.46 | 61.17 | 50.45 | 54.95 |
| Current ratioi | 32.84 | 43.19 | 23.71 | 16.90 | 16.80 | 32.05 | 28.40 | 28.21 |
| Quick ratioi | 26.76 | 37.48 | 19.54 | 14.65 | 12.93 | 24.47 | 21.66 | 20.37 |
| Debt / assetsi | 0.00 | 1.05 | 1.01 | 0.89 | 0.75 | 0.53 | 1.43 | 1.50 |
| LT debt / equityi | -- | 0.91 | 0.82 | 0.69 | 0.51 | 0.27 | 1.35 | 1.27 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -1.52 | -3.55 | -10.56 | 0.64 | 14.61 | 11.73 | -1.39 | -11.71 |
| Net income CAGR (3Y) %i | 5.68 | 3.91 | -5.63 | 0.00 | 16.03 | 13.56 | 1.26 | -12.51 |
| FCF CAGR (3Y) %i | 0.31 | 10.14 | -2.94 | -5.30 | 4.65 | 11.08 | 2.79 | -7.29 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 23.57 | 23.09 | 22.20 | 23.36 | 25.22 | 29.81 |
| ROA %i | 22.99 | 22.33 | 21.71 | 22.74 | 24.39 | 28.67 |
| ROIC %i | 20.87 | 20.36 | 19.44 | 20.46 | 22.21 | 26.83 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 61.81 | 61.08 | 59.11 | 59.49 | 60.46 | 62.07 |
| FCF / sales %i | 50.45 | 48.62 | 52.64 | 47.72 | 54.95 | 49.86 |
| Current ratioi | 28.40 | 16.10 | 29.64 | 34.84 | 28.21 | 23.72 |
| Quick ratioi | 21.66 | 11.13 | 20.80 | 25.84 | 20.37 | 18.83 |
| Debt / assetsi | 1.43 | 1.40 | 1.57 | 1.56 | 1.50 | 1.46 |
| LT debt / equityi | 1.35 | 1.37 | 1.35 | 1.33 | 1.27 | 1.18 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-09 19:30:06 · For reference only, not investment advice and not tailored to your situation.
NVE Corp discussion 0 comments